Rhodococcus Genome Project, Genome BC Team, Canada

Linear plasmids pRHL1, pRHL2, and pRHL3 lenti vectors

Key Sociocultural Method of Camelback Leisure Driving

Key Sociocultural Method of Camelback Leisure Driving

Zebrafish mannequin of human Zellweger syndrome reveals organ-specific accumulation of distinct fatty acid species and widespread gene expression modifications
In Zellweger syndrome (ZS), lack of peroxisome perform causes physiological and developmental abnormalities in lots of organs such because the mind, liver, muscle mass, and kidneys, however little is thought concerning the precise pathogenic mechanism.
By disrupting the zebrafish pex2 gene, we established a illness mannequin for ZS and located that it reveals pathological options and metabolic modifications just like these noticed in human sufferers. By complete evaluation of the fatty acid profile, we discovered organ-specific accumulation and discount of distinct fatty acid species, akin to an accumulation of ultra-very-long-chain polyunsaturated fatty acids (ultra-VLC-PUFAs) within the brains of pex2 mutant fish.
Transcriptome evaluation utilizing microarray additionally revealed mutant-specific gene expression modifications which may result in the signs, together with discount of crystallin, troponin, parvalbumin, and fatty acid metabolic genes.
Our information indicated that the lack of peroxisomes leads to widespread metabolic and gene expression modifications past the causative peroxisomal perform. These outcomes recommend the genetic and metabolic foundation of the pathology of this devastating human illness.

Camel Genetic Property Conservation by Tourism: A Key Sociocultural Methodology of Camelback Leisure Driving

  • Camels are distinctive elements, which can be comprised inside journey journey companies promoting ecotourism actions. Such recreations contribute to sustainable livelihoods for native communities and educational empowerment within the route of nature and its conservation.
  • At present, some native camel breeds’ survival reduces to this animal-based leisure enterprise and its reliability to hold out and promote custom-made corporations By conducting an on-site questionnaire to prospects participating in camelback driving excursions, we assessed the motivational parts affecting participation, satisfaction, and loyalty on this tourism section that may have made it socially differentiated.
  • The sixfold combination of employees effectivity, custom geography, quite a few and humane shut interaction, camel conduct and effectivity, sociotemporal context, and constructive earlier experience contains the elemental dimensions that designate purchaser satisfaction and return intention probability inside this leisure enterprise.
  • Purchaser information is essential for stakeholders to assemble personalised driving experiences and align revenue with environmental sustainability and biodiversity mainstream concerns into their regularly operations. In flip, residence camel vacationer rides is perhaps managed as a viable path to nature conservation by serving to endangered native breeds to avoid their helpful devaluation and potential extinction.
rhodococcus
rhodococcus

Fenretinide
GP8861 10mg
EUR 101.33

Fenretinide
GP8861-10 10
EUR 63.3

Fenretinide
GP8861-10MG 10 mg
EUR 112.8

Fenretinide
GP8861-25 25
EUR 110.7

Fenretinide
GP8861-25MG 25 mg
EUR 170.4

Fenretinide
F250000 25mg
EUR 106
Description: 65646-68-6

Fenretinide
HY-15373 10mM/1mL
EUR 127.71
Description: Fenretinide (4-HPR) is a synthetic retinoid deriverative, binding to the retinoic acid receptors (RAR) at concentrations necessary to induce cell death.

Fenretinide
MBS576264-100mg 100mg
EUR 200

Fenretinide
MBS576264-10mg 10mg
EUR 145

Fenretinide
MBS576264-25mg 25mg
EUR 170

Fenretinide
MBS576264-50mg 50mg
EUR 180

Fenretinide
MBS576264-5mg 5mg
EUR 145

Fenretinide
MBS384058-100mg 100mg
EUR 220

Fenretinide
MBS384058-25mg 25mg
EUR 160

Fenretinide
MBS384058-50mg 50mg
EUR 180

Fenretinide
MBS384058-5x100mg 5x100mg
EUR 990

Fenretinide
MBS3605494-100mg 100mg
EUR 260

Fenretinide
MBS3605494-10mg 10mg
EUR 210

Fenretinide
MBS3605494-25mg 25mg
EUR 235

Fenretinide
MBS3605494-50mg 50mg
EUR 245

Fenretinide
MBS3605494-5mg 5mg
EUR 200

Fenretinide
T1872-10mg 10mg Ask for price
Description: Fenretinide

Fenretinide
T1872-1g 1g Ask for price
Description: Fenretinide

Fenretinide
T1872-1mg 1mg Ask for price
Description: Fenretinide

Fenretinide
T1872-50mg 50mg Ask for price
Description: Fenretinide

Fenretinide
T1872-5mg 5mg Ask for price
Description: Fenretinide

Fenretinide-d4
F250002 25mg
EUR 1200

Fenretinide-d4
HY-110360 Get quote Ask for price
Description: Fenretinide-d4 is the deuterium labeled Fenretinide.

Fenretinide (4-HPR)
abx282632-100g 100 µg Ask for price

Fenretinide (4-HPR)
abx282632-20g 20 µg
EUR 143.75

Fenretinide (4-HPR)
abx282632-50g 50 µg
EUR 362.5

3-Hydroxy Fenretinide
H825635 50mg
EUR 4500
Description: 1027233-22-2

Fenretinide [CAS# 65646-68-6]
F-4077 10 mg
EUR 39

4-Methoxy Fenretinide-13C,d3
M262662 25mg
EUR 3000

Fenretinide glucuronide-d4
HY-143957S 1mg Ask for price
Description: Fenretinide glucuronide-d4 is the deuterium labeled Fenretinide glucuronide[1].

4'-Hydroxy Fenretinide-d4
HY-143958S 1mg Ask for price
Description: 4'-Hydroxy Fenretinide-d4 is the deuterium labeled 4'-Hydroxy Fenretinide[1].

3-Hydroxy Fenretinide-d4
H825637 25mg
EUR 4500

4-Methoxy Fenretinide-d4
M262661 10mg
EUR 1200

Fenretinide Glucuronide Monosodium Salt
F250010 500mg
EUR 11200
Description: 76177-99-6

Fenretinide (N-(4-Hydroxyphenyl)retinamide)
MBS6081236-10mg 10(mg
EUR 500

Fenretinide (N-(4-Hydroxyphenyl)retinamide)
MBS6081236-5x10mg 5x10mg
EUR 2090

Fenretinide Glucuronide Monosodium Salt-d4
F250012 100mg
EUR 11200

13-cis-Fenretinide
F250005 100mg
EUR 1455
Description: 75686-07-6

13-cis-Fenretinide-d4
F250007 25mg
EUR 1200

Fen1/ Rat Fen1 ELISA Kit
ELI-27513r 96 Tests
EUR 1063.2

FEN1, 1-380aa, Human, E Coli
MBS203445-002mg 0.02mg
EUR 230

FEN1, 1-380aa, Human, E Coli
MBS203445-01mg 0.1mg
EUR 405

FEN1, 1-380aa, Human, E Coli
MBS203445-05mg 0.5mg
EUR 985

FEN1, 1-380aa, Human, E Coli
MBS203445-5x05mg 5x0.5mg
EUR 4180

FEN1 (NM_004111) Human Recombinant Protein
E45H41222M5 20 ug
EUR 785.42

Fen1 (NM_007999) Mouse Recombinant Protein
E45M43496M5 20 ug
EUR 1924.54

FEN1 (NM_004111) Human Over-expression Lysate
E45H19061-2 20 ug
EUR 395

FEN1 (NM_004111) Human Over-expression Lysate
LS002237 100ug
EUR 628
Description: Transient overexpression lysate of flap structure-specific endonuclease 1 (FEN1)

1000 ug/mL Fenthion in Acetone - 1ML
S-2010-AC 1ML
EUR 189

1000 ug/mL Fenobucarb in Acetone - 1ML
S-4610-AC 1ML
EUR 106.65

FEN1
CSB-CL008585HU 10 μg plasmid + 200μl Glycerol Ask for price

FEN1
enz-468 5µg
EUR 60
Description: Recombinant Human Flap Structure-Specific Endonuclease 1

FEN1
MBS8561543-01mLAF405L 0.1mL(AF405L)
EUR 565

FEN1
MBS8561543-01mLAF405S 0.1mL(AF405S)
EUR 565

FEN1
MBS8561543-01mLAF610 0.1mL(AF610)
EUR 565

FEN1
MBS8561543-01mLAF635 0.1mL(AF635)
EUR 565

FEN1
MBS8561543-02mL 0.2mL
EUR 345

1000 ug/mL Fenpyroximate in Acetone - 1ML
S-5804 1ML
EUR 259.2

Lenti ORF particles, Fen1 (GFP-tagged) - Mouse flap structure specific endonuclease 1 (Fen1), 200ul, >10^7 TU/mL
MR220960L4V 200 µl Ask for price

Lenti ORF particles, Fen1 (GFP-tagged ORF) - Rat flap structure-specific endonuclease 1 (Fen1), 200ul, >10^7 TU/mL
RR207787L4V 200 µl Ask for price

Lenti ORF particles, Fen1 (Myc-DDK-tagged) - Mouse flap structure specific endonuclease 1 (Fen1), 200ul, >10^7 TU/mL
MR220960L3V 200 µl Ask for price

Lenti ORF particles, FEN1 (Myc-DDK tagged) - Human flap structure-specific endonuclease 1 (FEN1), 200ul, >10^7 TU/mL
RC201785L1V 200 µl Ask for price

Lenti ORF particles, FEN1 (mGFP-tagged) - Human flap structure-specific endonuclease 1 (FEN1), 200ul, >10^7 TU/mL
RC201785L2V 200 µl Ask for price

Lenti ORF particles, FEN1 (Myc-DDK tagged) - Human flap structure-specific endonuclease 1 (FEN1), 200ul, >10^7 TU/mL
RC201785L3V 200 µl Ask for price

Lenti ORF particles, FEN1 (mGFP-tagged) - Human flap structure-specific endonuclease 1 (FEN1), 200ul, >10^7 TU/mL
RC201785L4V 200 µl Ask for price

FEN1-IN-2
HY-122695 10 mg
EUR 1028.15
Description: FEN1-IN-2 (compound 20) is a flap endonuclease 1 (FEN1) inhibitor, with IC50 values of 3 nM and 226 nM for FEN1 and XPG, respectively[1].

FEN1-IN-1
HY-123834 1 mg
EUR 205.63
Description: FEN1-IN-1 (compound 1) is a flap endonuclease 1 (FEN1) inhibitor. FEN1-IN-1 binds to the active site of FEN1 and partly achieves inhibition by the co-ordination of Mg2+ ions[1].

FEN1-IN-3
HY-136484 10 mg
EUR 487.02
Description: FEN1-IN-3 (Compound 4) is a human flap endonuclease-1 (hFEN1) inhibitor. FEN1-IN-3 stabilizes hFEN1 with an EC50 of 6.8 μM[1].

FEN1-IN-4
HY-136485 1 mg
EUR 535.72
Description: FEN1-IN-4 (Compound 2) is a human flap endonuclease-1 (hFEN1) inhibitor[1].

FEN1-IN-5
HY-153790 10 mg
EUR 308.45
Description: FEN1-IN-5 (compound 12A) is a potent inhibitor of Flap endonuclease-1 (FEN1, IC50=12 nM), involving in DNA repair[1].

FEN1-IN-6
HY-153791 Get quote Ask for price
Description: FEN1-IN-6 (compound 9) is a potent inhibitor of Flap endonuclease-1 (FEN1, IC50=10 nM), involving in mammalian cells to repair DNA damage. FEN1-IN-6 also targets to related endonuclease, xeroderma pigmentosum G (XPG) with an IC50 value of 23 nM[1].

FEN1-IN-7
HY-153792 Get quote Ask for price
Description: FEN1-IN-7 (compound 16) is a selective inhibitor of Flap endonuclease-1 (FEN1, IC50=18 nM), involving in mammalian cells to repair DNA damage. FEN1-IN-7 also targets to related endonuclease, xeroderma pigmentosum G (XPG) with an IC50 value of 3.04 μM. FEN1-IN-7 increases the cellular sensitivity of cancer cells to potent DNA alkylating agents or methylating agents[1].

FEN1-IN-1
MBS133109-INQUIRE INQUIRE Ask for price

FEN1-IN-1
MBS5754862-10mg 10mg
EUR 170

FEN1-IN-1
MBS5754862-25mg 25mg
EUR 195

FEN1-IN-1
MBS5754862-2mg 2mg
EUR 145

FEN1-IN-1
MBS5754862-50mg 50mg
EUR 240

FEN1-IN-1
MBS5754862-5mg 5mg
EUR 150

FEN1-IN-2
MBS5801085-5mg 5(mg
EUR 915

FEN1-IN-2
MBS5801085-5x5mg 5x5(mg
EUR 3970

FEN1-IN-1
T15274-10mg 10mg Ask for price
Description: FEN1-IN-1

FEN1-IN-1
T15274-1g 1g Ask for price
Description: FEN1-IN-1

FEN1-IN-1
T15274-1mg 1mg Ask for price
Description: FEN1-IN-1

FEN1-IN-1
T15274-50mg 50mg Ask for price
Description: FEN1-IN-1

FEN1-IN-1
T15274-5mg 5mg Ask for price
Description: FEN1-IN-1

FEN1-IN-2
T40931-10mg 10mg Ask for price
Description: FEN1-IN-2

FEN1-IN-2
T40931-1g 1g Ask for price
Description: FEN1-IN-2

FEN1-IN-2
T40931-1mg 1mg Ask for price
Description: FEN1-IN-2

FEN1-IN-2
T40931-50mg 50mg Ask for price
Description: FEN1-IN-2

FEN1-IN-2
T40931-5mg 5mg Ask for price
Description: FEN1-IN-2

FEN1-IN-4
T8545-10mg 10mg Ask for price
Description: FEN1-IN-4

FEN1-IN-4
T8545-1g 1g Ask for price
Description: FEN1-IN-4

FEN1-IN-4
T8545-1mg 1mg Ask for price
Description: FEN1-IN-4

FEN1-IN-4
T8545-50mg 50mg Ask for price
Description: FEN1-IN-4

FEN1-IN-4
T8545-5mg 5mg Ask for price
Description: FEN1-IN-4

FEN1-IN-3
T9147-10mg 10mg Ask for price
Description: FEN1-IN-3

FEN1-IN-3
T9147-1g 1g Ask for price
Description: FEN1-IN-3

FEN1-IN-3
T9147-1mg 1mg Ask for price
Description: FEN1-IN-3

FEN1-IN-3
T9147-50mg 50mg Ask for price
Description: FEN1-IN-3

FEN1-IN-3
T9147-5mg 5mg Ask for price
Description: FEN1-IN-3

1000 ug/mL Fenamidone in HPLC Acetonitrile - 1ML
LCS-4966 1ML
EUR 390.15

1000 ug/mL Fenazaquin in HPLC Acetonitrile - 1ML
LCS-6019 1ML
EUR 398.25

1000 ug/mL of Fenitrothion in Acetone 1mL Ampule - 1ML
S-2001 1ML
EUR 67.5

Fen1 (untagged ORF) - Rat flap structure-specific endonuclease 1 (Fen1), (10 ug)
RN207787 10 µg Ask for price

Lenti ORF particles, Fen1 (Myc-DDK-tagged ORF) - Rat flap structure-specific endonuclease 1 (Fen1), 200ul, >10^7 TU/mL
RR207787L3V 200 µl Ask for price

Fen1 (GFP-tagged) - Mouse flap structure specific endonuclease 1 (Fen1), (10ug)
MG220960 10 µg Ask for price

Fen1 (untagged) - Mouse flap structure specific endonuclease 1 (Fen1), (10ug)
MC208478 10 µg Ask for price

FEN1 (untagged)-Human flap structure-specific endonuclease 1 (FEN1)
SC110892 10 µg Ask for price

FEN1 (GFP-tagged) - Human flap structure-specific endonuclease 1 (FEN1)
RG201785 10 µg Ask for price

1000 ug/mL (E)-Fenpyroximate in Acetonitrile - 1ML
S-6179 1ML
EUR 136.35

Rat FEN1 siRNA
20-abx916746
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

FEN1 siRNA (Rat)
MBS8223612-15nmol 15nmol
EUR 405

FEN1 siRNA (Rat)
MBS8223612-30nmol 30nmol
EUR 565

FEN1 siRNA (Rat)
MBS8223612-5x30nmol 5x30nmol
EUR 2450

FEN-1 mouse mAb
UB-GEN-1074 100 ul
EUR 200

FEN-1 mouse mAb
UB-GEN-1075 100 ul
EUR 200

Fen1 (Myc-DDK-tagged) - Mouse flap structure specific endonuclease 1 (Fen1)
MR220960 10 µg Ask for price

Fen1 (Myc-DDK-tagged ORF) - Rat flap structure-specific endonuclease 1 (Fen1), (10 ug)
RR207787 10 µg Ask for price

FEN1 protein
30R-1442 100 ug
EUR 410
Description: Purified recombinant Human FEN1 protein

FEN-1 Rabbit mAb
A8999 20 μL
EUR 1657.89
Description: A synthetic peptide corresponding to a sequence within amino acids 5000-5100 of human MUC2 (Q02817).

FEN1 Rabbit mAb
59492 100ul
EUR 339

FEN-1 Rabbit pAb
A1175 200μL
EUR 173.58

FEN1 Rabbit pAb
A1175-200ul 200 ul
EUR 550.8

FEN1 Rabbit pAb
A1175-20ul 20 ul
EUR 219.6

FEN-1 Rabbit pAb
A0129 200μL
EUR 173.58

FEN1 Rabbit pAb
A0129-100ul 100 ul
EUR 369.6

FEN1 Rabbit pAb
A0129-200ul 200 ul
EUR 550.8

FEN1 Rabbit pAb
A0129-20ul 20 ul Ask for price

FEN1 Rabbit pAb
A0129-50ul 50 ul Ask for price

FEN1 Rabbit mAb
52758 100ul
EUR 499

FEN1 Rabbit mAb
E2R26747 100ul
EUR 255
Description: Available in various conjugation types.

FEN1 Rabbit mAb
E2R381904 100ul
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

FEN1 Rabbit pAb
E2501175 100ul
EUR 225
Description: Available in various conjugation types.

FEN1 Rabbit pAb
E2381904 100ul
EUR 225
Description: Available in various conjugation types.

FEN-1 Rabbit pAb
E45R18628N 50 ul
EUR 297.75

FEN-1 Rabbit mAb
E45R12158N 50 ul
EUR 346.5

FEN1 cDNA Clone
MBS1271477-001mgPlasmid02mLGlycerolStock 0.01mgPlasmid+0.2mLGlycerol-Stock
EUR 200

FEN1 cDNA Clone
MBS1271477-5x001mgPlasmid5x02mLGlycerolStock 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock
EUR 855

FEN1 Rabbit mAb
MBS4753269-01mL 0.1mL
EUR 450

FEN1 Rabbit mAb
MBS4753269-5x01mL 5x0.1mL
EUR 1540

FEN1 Peptide
MBS3233014-01mg 0.1mg
EUR 180

FEN1 Peptide
MBS3233014-5x01mg 5x0.1mg
EUR 730

FEN1 Rabbit pAb
MBS8543368-01mL 0.1mL
EUR 305

FEN1 Rabbit pAb
MBS8543368-01mLAF405L 0.1mL(AF405L)
EUR 565

FEN1 Rabbit pAb
MBS8543368-01mLAF405S 0.1mL(AF405S)
EUR 565

FEN1 Rabbit pAb
MBS8543368-01mLAF610 0.1mL(AF610)
EUR 565

FEN1 Rabbit pAb
MBS8543368-01mLAF635 0.1mL(AF635)
EUR 565

FEN1 Rabbit pAb
MBS8544285-01mL 0.1mL
EUR 305

FEN1 Rabbit pAb
MBS8544285-01mLAF405L 0.1mL(AF405L)
EUR 565

FEN1 Rabbit pAb
MBS8544285-01mLAF405S 0.1mL(AF405S)
EUR 565

FEN1 Rabbit pAb
MBS8544285-01mLAF610 0.1mL(AF610)
EUR 565

FEN1 Rabbit pAb
MBS8544285-01mLAF635 0.1mL(AF635)
EUR 565

FEN1 Rabbit mAb
MBS9467471-005mL 0.05mL
EUR 290

FEN1 Rabbit mAb
MBS9467471-01mL 0.1mL
EUR 435

FEN1 Rabbit mAb
MBS9467471-5x01mL 5x0.1mL
EUR 1810

1000 ug/mL (E)-Fenpyroximate in HPLC Acetonitrile - 1ML
LCS-6179 1ML
EUR 398.25

1000 ug/mL Fenpyroximate in HPLC Acetonitrile - 1ML
LCS-6387 1ML
EUR 218.7

1000 ug/mL Fenthion sulfoxide in Acetonitrile - 1ML
S-4316-ACN 1ML
EUR 125.55

FEN1 (Myc-DDK-tagged)-Human flap structure-specific endonuclease 1 (FEN1)
RC201785 10 µg Ask for price

FEN1 Antibody
MBS7132756-01mL 0.1mL
EUR 270

FEN1 Antibody
MBS7132756-5x01mL 5x0.1mL
EUR 1200

FEN1 Antibody
MBS7134535-005mL 0.05mL
EUR 190

FEN1 Antibody
MBS7134535-01mL 0.1mL
EUR 270

FEN1 Antibody
MBS7134535-5x01mL 5x0.1mL
EUR 1205

FEN1 Antibody
MBS7047709-005mg 0.05mg
EUR 190

FEN1 Antibody
MBS7047709-01mg 0.1mg
EUR 270

FEN1 Antibody
MBS7047709-5x01mg 5x0.1mg
EUR 1205

FEN1 Antibody
MBS7114815-005mL 0.05mL
EUR 220

FEN1 Antibody
MBS7114815-01mL 0.1mL
EUR 300

FEN1 Antibody
MBS7114815-5x01mL 5x0.1mL
EUR 1350

FEN1 Antibody
MBS7122012-005mg 0.05mg
EUR 150

FEN1 Antibody
MBS7122012-01mg 0.1mg
EUR 190

FEN1 Antibody
MBS7122012-5x01mg 5x0.1mg
EUR 845

FEN1 antibody
10R-1738 100 ug
EUR 614.4
Description: Mouse monoclonal FEN1 antibody

FEN1 Antibody
33763 100ul
EUR 319

FEN1 Antibody
33763-100ul 100ul
EUR 302.4

FEN1 Antibody
33763-50ul 50ul
EUR 224.4

FEN1 Antibody
32204 100ul
EUR 439

FEN1 Antibody
32204-100ul 100ul
EUR 302.4

FEN1 Antibody
CAC11682-100ul 100ul
EUR 314

FEN1 Antibody
CAC11682-50ul 50ul
EUR 199.2

FEN1 Antibody
8C10585 50ug
EUR 368
Description: FEN1 Antibody

FEN1 antibody
70R-49736 100 ul
EUR 242
Description: Purified Polyclonal FEN1 antibody

FEN1 antibody
70R-1605 100 ug
EUR 407
Description: Rabbit polyclonal FEN1 antibody raised against the C terminal of FEN1

FEN1 antibody
70R-17281 50 ul
EUR 289
Description: Rabbit polyclonal FEN1 antibody

FEN1 antibody
70R-31706 100 ug
EUR 294
Description: Rabbit polyclonal FEN1 antibody

FEN1 Antibody
abx243080-96tests 96 tests
EUR 287.5

Human FEN1 siRNA
20-abx916747
  • Ask for price
  • Ask for price
  • 15 nmol
  • 30 nmol

FEN-1 Antibody
C10585-100ul 100μl
EUR 217
Description: FEN-1 Rabbit Polyclonal Antibody

FEN-1 Antibody
C10585-50ul 50μl
EUR 143.5
Description: FEN-1 Rabbit Polyclonal Antibody

Single cell transcriptomes reveal expression patterns of chemoreceptor genes in olfactory sensory neurons of the Caribbean spiny lobster, Panulirus argus

Background: Crustaceans categorical numerous programs of receptor genes of their antennules, which residence olfactory sensory neurons (OSNs) and non-olfactory chemosensory neurons.

Transcriptomics analysis reveal that candidate chemoreceptor proteins embrace variant Ionotropic Receptors (IRs) along with every co-receptor IRs and tuning IRs, Transient Receptor Potential (TRP) channels, Gustatory Receptors, epithelial sodium channels, and class A G-protein coupled receptors (GPCRs).

The Caribbean spiny lobster, Panulirus argus, expresses in its antennules nearly 600 IRs, 17 TRP channels, 1 Gustatory Receptor, 7 epithelial sodium channels, 81 GPCRs, 6 G proteins, and dozens of enzymes in signaling pathways.

However, the exact combinatorial expression patterns of these proteins in single sensory neurons normally should not acknowledged for any crustacean, limiting our understanding of how their chemosensory strategies encode chemical top quality.

Outcomes: The aim of this analysis was to utilize transcriptomics to clarify expression patterns of chemoreceptor genes in OSNs of P. argus. We generated and analyzed transcriptomes from 7 single OSNs, a number of of which have been confirmed to reply a meals odor, along with an extra 7 multicell transcriptomes from preparations containing few (2-4), numerous (ca. 15), or many (ca. 400) OSNs. We found that each OSN expressed the similar 2 co-receptor IRs (IR25a, IR93a) nevertheless

 

not the other 2 antennular coIRs (IR8a, IR76b), 9-53 tuning IRs nevertheless only one to some in extreme abundance, the similar 5 TRP channels plus as a lot as 5 further TRPs, 12-17 GPCRs along with the similar 5 expressed in every single cell transcriptome, the similar Three G proteins plus others, many enzymes throughout the signaling pathways, nevertheless no Gustatory Receptors or epithelial sodium channels. The very best distinction in receptor expression among the many many OSNs was the identification of the tuning IRs.

 

Conclusions: Our outcomes current an preliminary view of the combinatorial expression patterns of receptor molecules in single OSNs in a single species of decapod crustacean, along with receptors straight involved in olfactory transduction and others probably involved in modulation. Our outcomes moreover counsel variations in receptor expression in OSNs vs. completely different chemosensory neurons.

An embedded gene choice methodology utilizing knockoffs optimizing neural community

Background: Gene alternative refers to find a small subset of discriminant genes from the gene expression profiles. The way in which to decide on genes that affect specific phenotypic traits efficiently is a crucial evaluation work throughout the topic of biology. The neural neighborhood has increased turning into functionality when dealing with nonlinear info, and it’ll most likely seize choices robotically and flexibly. On this work, we advise an embedded gene alternative methodology using neural neighborhood.

The important genes could also be obtained by calculating the burden coefficient after the teaching is completed. In an effort to treatment the problem of black discipline of neural neighborhood and extra make the teaching outcomes interpretable in neural neighborhood, we use the idea of knockoffs to assemble the knockoff attribute genes of the distinctive attribute genes.

This system not solely make each attribute gene to compete with each other, however moreover make each attribute gene compete with its knockoff attribute gene. This methodology might assist to choose the necessary factor genes that affect the decision-making of neural networks.

Outcomes: We use maize carotenoids, tocopherol methyltransferase, raffinose family oligosaccharides and human breast most cancers dataset to do verification and analysis.

Conclusions: The experiment outcomes show that the knockoffs optimizing neural neighborhood methodology has increased detection influence than the other current algorithms, and particularly for processing the nonlinear gene expression and phenotype info.

 

 

Afatinib free base
MBS5756697-10mg 10mg
EUR 145

Afatinib free base
MBS5756697-200mg 200mg
EUR 250

Afatinib free base
MBS5756697-50mg 50mg
EUR 195

Afatinib free base
MBS5756697-5x200mg 5x200mg
EUR 965

Afatinib, Free Base [CAS# 850140-72-6]
A-8644 25 mg
EUR 46

Afatinib
27009 25 mg
EUR 115
Description: Afatinib, also known as BIW-2992, is an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinases. Afatinib suppresses EGF-induced EGFR phosphorylation and cellular proliferation in various cell lines, including EGFR-overexpressing and HER2-expressing cell lines A431, NIH-3T3-HER2, NCI-N87 and BT-474.

Afatinib
A170-100MG 100mg
EUR 63.39
Description: 850140-72-6

Afatinib
A355300 100mg
EUR 68
Description: 850140-72-6

Afatinib
GW6150 1mg
EUR 395.63

Afatinib
GW6150-1 1
EUR 171.5

Afatinib
GW6150-10 10
EUR 368.2

Afatinib
GW6150-5 5
EUR 237.4

Afatinib
HY-10261 200mg
EUR 155.85
Description: Afatinib (BIBW 2992) is an orally active, potent and irreversible dual specificity inhibitor of ErbB family (EGFR and HER2), with IC50 values of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively. Afatinib can be used for the research of esophageal squamous cell carcinoma (ESCC), non-small cell lung cancer (NSCLC) and gastric cancer[1][2][3][4].

Afatinib
MBS3604489-10mg 10mg
EUR 260

Afatinib
MBS3604489-25mg 25mg
EUR 325

Afatinib
MBS3604489-2mg 2mg
EUR 200

Afatinib
MBS3604489-50mg 50mg
EUR 435

Afatinib
MBS3604489-5mg 5mg
EUR 215

Afatinib
MBS3842612-100mg 100mg
EUR 425

Afatinib
MBS3842612-10mg 10mg
EUR 140

Afatinib
MBS3842612-25mg 25mg
EUR 200

Afatinib
MBS3842612-50mg 50mg
EUR 275

Afatinib
MBS3842612-5x100mg 5x100mg
EUR 1910

Afatinib
T21312-10mg 10mg Ask for price
Description: Afatinib

Afatinib
T21312-1g 1g Ask for price
Description: Afatinib

Afatinib
T21312-1mg 1mg Ask for price
Description: Afatinib

Afatinib
T21312-50mg 50mg Ask for price
Description: Afatinib

Afatinib
T21312-5mg 5mg Ask for price
Description: Afatinib

(R)-Afatinib
C597485 10mg
EUR 969
Description: 945553-91-3

(2Z)-Afatinib
A355305 0.5mg
EUR 2113
Description: 1680184-59-1

(R)-Afatinib
HY-10261E Get quote Ask for price
Description: (R)-Afatinib ((R)-BIBW 2992) is the Afatinib isomer. Afatinib (HY-10261) is an orally active, potent and irreversible dual specificity inhibitor of ErbB family (EGFR and HER2), with IC50 values of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively. Afatinib can be used for the research of esophageal squamous cell carcinoma (ESCC), non-small cell lung cancer (NSCLC) and gastric cancer[1].

Afatinib D6
T10256-10mg 10mg Ask for price
Description: Afatinib D6

Afatinib D6
T10256-1g 1g Ask for price
Description: Afatinib D6

Afatinib D6
T10256-1mg 1mg Ask for price
Description: Afatinib D6

Afatinib D6
T10256-50mg 50mg Ask for price
Description: Afatinib D6

Afatinib D6
T10256-5mg 5mg Ask for price
Description: Afatinib D6

Afatinib-d4
A355302 25mg
EUR 15000

Afatinib-d6
A355303 10mg
EUR 628
Description: 1313874-96-2

Afatinib-d6
HY-10261S 1 mg
EUR 616.89
Description: Afatinib-d6 is deuterium labeled Afatinib. Afatinib (BIBW 2992) is an irreversible EGFR family inhibitor[1].

Afatinib-d4
HY-10261S1 1mg Ask for price
Description: Afatinib-d4 is the deuterium labeled Afatinib. Afatinib (BIBW 2992) is an irreversible EGFR family inhibitor with IC50s of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively.

Afatinib Dimer
A355310 25mg
EUR 12800

Afatinib (oxalate)
HY-10261D Get quote Ask for price
Description: Afatinib (BIBW 2992) oxalate is an orally active, potent and irreversible dual specificity inhibitor of ErbB family (EGFR and HER2), with IC50 values of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively. Afatinib oxalate can be used for the research of esophageal squamous cell carcinoma (ESCC), non-small cell lung cancer (NSCLC) and gastric cancer[1][2][3][4].

Afatinib oxalate
T64075-10mg 10mg Ask for price
Description: Afatinib oxalate

Afatinib oxalate
T64075-1g 1g Ask for price
Description: Afatinib oxalate

Afatinib oxalate
T64075-1mg 1mg Ask for price
Description: Afatinib oxalate

Afatinib oxalate
T64075-50mg 50mg Ask for price
Description: Afatinib oxalate

Afatinib oxalate
T64075-5mg 5mg Ask for price
Description: Afatinib oxalate

Afatinib (BIBW2992)
A8247-10 10 mg
EUR 68
Description: JAK/STAT Signaling|EGFR#Tyrosine Kinase|EGFR#Tyrosine Kinase|HER2

Afatinib (BIBW2992)
A8247-5 5 mg
EUR 40
Description: JAK/STAT Signaling|EGFR#Tyrosine Kinase|EGFR#Tyrosine Kinase|HER2

Afatinib (BIBW2992)
A8247-5.1 10 mM (in 1mL DMSO)
EUR 60
Description: JAK/STAT Signaling|EGFR#Tyrosine Kinase|EGFR#Tyrosine Kinase|HER2

Afatinib (BIBW2992)
A8247-50 50 mg
EUR 88
Description: JAK/STAT Signaling|EGFR#Tyrosine Kinase|EGFR#Tyrosine Kinase|HER2

Afatinib (BIBW2992)
A8247-S Evaluation Sample
EUR 24
Description: JAK/STAT Signaling|EGFR#Tyrosine Kinase|EGFR#Tyrosine Kinase|HER2

BIBW2992 (Afatinib)
MBS386306-100mg 100mg
EUR 285

BIBW2992 (Afatinib)
MBS386306-10mg 10mg
EUR 140

BIBW2992 (Afatinib)
MBS386306-1mLinDMSO 1mL(inDMSO)
EUR 140

BIBW2992 (Afatinib)
MBS386306-25mg 25mg
EUR 160

BIBW2992 (Afatinib)
MBS386306-5mg 5mg
EUR 130

Afatinib (BIBW2992)
MBS578066-10mg 10mg
EUR 195

Afatinib (BIBW2992)
MBS578066-25mg 25mg
EUR 260

Afatinib (BIBW2992)
MBS578066-2mg 2mg
EUR 145

Afatinib (BIBW2992)
MBS578066-50mg 50mg
EUR 370

Afatinib (BIBW2992)
MBS578066-5mg 5mg
EUR 155

Afatinib dimaleate
120204 100.0mg
EUR 90

Afatinib dimaleate
A3145-10 10 mg
EUR 56
Description: Tyrosine Kinase|HER2

Afatinib dimaleate
A3145-5 5 mg
EUR 40
Description: Tyrosine Kinase|HER2

Afatinib dimaleate
A3145-5.1 10 mM (in 1mL DMSO)
EUR 48
Description: Tyrosine Kinase|HER2

Afatinib dimaleate
A3145-50 50 mg
EUR 88
Description: Tyrosine Kinase|HER2

Afatinib Dimaleate
A355315 1g
EUR 126
Description: 850140-73-7

Afatinib (dimaleate)
HY-10261A 200mg
EUR 171
Description: Afatinib (BIBW 2992) dimaleate is an orally active, potent and irreversible dual specificity inhibitor of ErbB family (EGFR and HER2), with IC50 values of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively. Afatinib dimaleate can be used for the research of esophageal squamous cell carcinoma (ESCC), non-small cell lung cancer (NSCLC) and gastric cancer[1][2][3][4].

Afatinib dimaleate
MBS3606168-100mg 100mg
EUR 275

Afatinib dimaleate
MBS3606168-10mg 10mg
EUR 210

Afatinib dimaleate
MBS3606168-200mg 200mg
EUR 320

Afatinib dimaleate
MBS3606168-25mg 25mg
EUR 225

Afatinib dimaleate
MBS3606168-50mg 50mg
EUR 250

Afatinib dimaleate
MBS3840747-100mg 100mg
EUR 240

Afatinib dimaleate
MBS3840747-25mg 25mg
EUR 165

Afatinib dimaleate
MBS3840747-50mg 50mg
EUR 200

Afatinib dimaleate
MBS3840747-5x100mg 5x100mg
EUR 1065

Afatinib Dimaleate
T1773-10mg 10mg Ask for price
Description: Afatinib Dimaleate

Afatinib Dimaleate
T1773-1g 1g Ask for price
Description: Afatinib Dimaleate

Afatinib Dimaleate
T1773-1mg 1mg Ask for price
Description: Afatinib Dimaleate

Afatinib Dimaleate
T1773-50mg 50mg Ask for price
Description: Afatinib Dimaleate

Afatinib Dimaleate
T1773-5mg 5mg Ask for price
Description: Afatinib Dimaleate

(E/Z)-Afatinib
HY-10261B 100 mg
EUR 54.11
Description: (E/Z)-Afatinib ((E/Z)-BIBW 2992) is the mixture of (E)-Afatinib and (Z)-Afatinib. Afatinib (HY-10261) is an irreversible inhibitor of EGFR, by irreversibly binding to their ATP binding site to block activation of EGFR, HER2, HER4, and EGFRvIII. Afatinib used in co-administration with Temozolomide (HY-17364), potently targeting to EGFRvIII-cMet signaling in glioblastoma cells[1].

BIBW 2992 (Afatinib)
abx283009-100g 100 µg Ask for price

BIBW 2992 (Afatinib)
abx283009-20g 20 µg
EUR 156.25

BIBW 2992 (Afatinib)
abx283009-50g 50 µg
EUR 387.5

(2Z)-Afatinib-d6
A355307 25mg
EUR 3000

Afatinib N-Oxide
A355330 25mg
EUR 1722

Afatinib N-Oxide
HY-133110 Get quote Ask for price
Description: Afatinib N-Oxide is an impurity of Afatinib dimaleate in oxidative degradation. Afatinib dimaleate is an irreversible EGFR family inhibitor[1].

Afatinib N-Oxide
T10257-10mg 10mg Ask for price
Description: Afatinib N-Oxide

Afatinib N-Oxide
T10257-1g 1g Ask for price
Description: Afatinib N-Oxide

Afatinib N-Oxide
T10257-1mg 1mg Ask for price
Description: Afatinib N-Oxide

Afatinib N-Oxide
T10257-50mg 50mg Ask for price
Description: Afatinib N-Oxide

Afatinib N-Oxide
T10257-5mg 5mg Ask for price
Description: Afatinib N-Oxide

Afatinib impurity 11
HY-133780 1 mg
EUR 1439.42
Description: Afatinib impurity 11 is an impurity of Afatinib. Afatinib is an irreversible EGFR family inhibitor with IC50s of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively[1].

Afatinib impurity 11
MBS5796779-1mg 1(mg
EUR 185

Afatinib impurity 11
MBS5796779-5mg 5(mg
EUR 345

Afatinib impurity 11
MBS5796779-5x5mg 5x5(mg
EUR 1410

Afatinib impurity 11
T35430-10mg 10mg Ask for price
Description: Afatinib impurity 11

Afatinib impurity 11
T35430-1g 1g Ask for price
Description: Afatinib impurity 11

Afatinib impurity 11
T35430-1mg 1mg Ask for price
Description: Afatinib impurity 11

Afatinib impurity 11
T35430-50mg 50mg Ask for price
Description: Afatinib impurity 11

Afatinib impurity 11
T35430-5mg 5mg Ask for price
Description: Afatinib impurity 11

3-Dechloro Afatinib
D226460 250mg
EUR 3000

Afatinib-d6 Dimaleate
A355317 10mg
EUR 437

Afatinib-d6 (dimaleate)
HY-10261AS 1mg Ask for price
Description: Afatinib-d6 (dimaleate) is the deuterium labeled Afatinib dimaleate. Afatinib dimaleate is an irreversible EGFR family inhibitor with IC50s of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively[1][2].

Afatinib (BIBW2992) Dimaleate
MBS577991-100mg 100mg
EUR 215

Afatinib (BIBW2992) Dimaleate
MBS577991-10mg 10mg
EUR 145

Afatinib (BIBW2992) Dimaleate
MBS577991-200mg 200mg
EUR 255

Afatinib (BIBW2992) Dimaleate
MBS577991-25mg 25mg
EUR 165

Afatinib (BIBW2992) Dimaleate
MBS577991-5mg 5mg
EUR 145

Afatinib Impurity AFT-8
A355335 100mg
EUR 1028
Description: 2323570-72-3

N3-(3-Dimethylamino,1-carboxyprop-2-yl) Afatinib
D471315 25mg
EUR 11200

EGFR/HER2 kinase inhibitor (>99%, M.wt 485.94) (Afatinib/BIBW-2992
SM-101000-5 5 mg
EUR 196.8

EGFR/HER2 kinase inhibitor (>99%, M.wt 485.94) (Afatinib/BIBW-2992
SM-101000-50 50 mg
EUR 781.2

Diethyl (S)-2-Amino-2-oxoethyl Phosphonate Afatinib
D355300 250mg
EUR 800
Description: 618061-76-0

Des(N,N-Dimethylprop-2-enyl-1-Amine) Afatinib
D291240 10mg
EUR 1631

3-Dechloro-4-defluoro 4-Chloro-3-fluoro Afatinib
D226455 100mg
EUR 3000

Deschloro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib
D289625 1g
EUR 1800

Desfluoro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib
D289815 2.5g
EUR 1800
Description: 2413212-09-4

Afatinib-des(4-dimethylamino-2-en-1-oxo)butyl (Contained ~8.5% Ethanol)
A355320 100mg
EUR 276
Description: 314771-76-1

Deschloro,desfluoro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib
D289635 2.5g
EUR 1800

Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(pyrrolidin-2,5-dion-1-yl) Afatinib
D291238 100mg
EUR 316

Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(5-Amino-pyrrolidin-2-on-1-yl) Afatinib
D291248 10mg
EUR 759

Des-(4-dimethylamino-2-en-1-oxo)butylamino 6-(5-Hydroxy-pyrrolidin-2-on-1-yl) Afatinib
D291245 10mg
EUR 874

Afamelanotide free base
330224 1.0mg
EUR 265

I-37 free base (2359690-13-2(free base))
MBS5759495-10mg 10mg
EUR 470

I-37 free base (2359690-13-2(free base))
MBS5759495-1mg 1mg
EUR 210

I-37 free base (2359690-13-2(free base))
MBS5759495-25mg 25mg
EUR 780

I-37 free base (2359690-13-2(free base))
MBS5759495-50mg 50mg
EUR 1130

I-37 free base (2359690-13-2(free base))
MBS5759495-5mg 5mg
EUR 335

I-37 free base( 2359690-13-2(free base))
T8721L-10mg 10mg Ask for price
Description: I-37 free base( 2359690-13-2(free base))

I-37 free base( 2359690-13-2(free base))
T8721L-1g 1g Ask for price
Description: I-37 free base( 2359690-13-2(free base))

I-37 free base( 2359690-13-2(free base))
T8721L-1mg 1mg Ask for price
Description: I-37 free base( 2359690-13-2(free base))

I-37 free base( 2359690-13-2(free base))
T8721L-50mg 50mg Ask for price
Description: I-37 free base( 2359690-13-2(free base))

I-37 free base( 2359690-13-2(free base))
T8721L-5mg 5mg Ask for price
Description: I-37 free base( 2359690-13-2(free base))

EDC free base
GM6988 5g
EUR 116.06

TMB free base
TB0954 1g
EUR 85.06

THZ1 (Free base)
9664-25 each
EUR 1227.6

THZ1 (Free base)
9664-5 each
EUR 352.8

R406 (free base)
A5880-100 100 mg
EUR 800
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk)

R406 (free base)
A5880-25 25 mg
EUR 320
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk)

R406 (free base)
A5880-5 5 mg
EUR 80
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk)

R406 (free base)
A5880-5.1 10 mM (in 1mL DMSO)
EUR 148
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk)

R406 (free base)
A5880-S Evaluation Sample
EUR 24
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk)

K201 free base
414202 5.0mg
EUR 288

FIPI free base
407955 200.0mg
EUR 1050

R406(free base)
E1KS1533 2mg
EUR 362.4

FIPI (free base)
B2372-25 each
EUR 757.2

FIPI (free base)
B2372-5 each
EUR 235.2

NG25 free base
562503 5.0mg
EUR 485

S107 free base
530577 100.0mg
EUR 750

SIS3 (free base)
HY-100444 10 mg
EUR 1244.61
Description: SIS3 free base is a potent and selective inhibitor of Smad3 phosphorylation. SIS3 free base inhibits the myofibroblast differentiation of fibroblasts by TGF-β1. SIS3 free base does not affect the phosphorylation of Smad2[1].

R406 (free base)
HY-11108 10mM/1mL
EUR 465.38
Description: R406 free base is an orally available and competitive Syk/FLT3 inhibitor for ATP binding with a Ki of 30 nM, potently inhibits Syk kinase activity in vitro with an IC50 of 41 nM, measured at an ATP concentration corresponding to its Km value. R406 free base reduces immune complex-mediated inflammation[1]. R406 free base also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM)[2].

R406(free base)
MBS131267-100mg 100mg
EUR 1065

R406(free base)
MBS131267-500mg 500mg
EUR 2775

SIS3 free base
MBS5767611-5mg 5mg
EUR 915

SIS3 free base
MBS5767611-5x5mg 5x5mg
EUR 3970

R406 free base
MBS3606124-10mg 10mg
EUR 305

R406 free base
MBS3606124-25mg 25mg
EUR 405

R406 free base
MBS3606124-2mg 2mg
EUR 235

R406 free base
MBS3606124-50mg 50mg
EUR 620

R406 free base
MBS3606124-5mg 5mg
EUR 260

R788 free base
MBS3606474-10mg 10mg
EUR 315

R788 free base
MBS3606474-25mg 25mg
EUR 430

R788 free base
MBS3606474-2mg 2mg
EUR 225

R788 free base
MBS3606474-5mg 5mg
EUR 260

R788 free base
MBS3606474-5x25mg 5x25mg
EUR 1620

R406 (free base)
MBS8506526-2mg 2mg
EUR 440

R406 (free base)
MBS8506526-5x2mg 5x2mg
EUR 1835

R406 free base
T2467-10mg 10mg Ask for price
Description: R406 free base

R406 free base
T2467-1g 1g Ask for price
Description: R406 free base

R406 free base
T2467-1mg 1mg Ask for price
Description: R406 free base

R406 free base
T2467-50mg 50mg Ask for price
Description: R406 free base

R406 free base
T2467-5mg 5mg Ask for price
Description: R406 free base

SIS3 free base
T12923-10mg 10mg Ask for price
Description: SIS3 free base

SIS3 free base
T12923-1g 1g Ask for price
Description: SIS3 free base

SIS3 free base
T12923-1mg 1mg Ask for price
Description: SIS3 free base

SIS3 free base
T12923-50mg 50mg Ask for price
Description: SIS3 free base

SIS3 free base
T12923-5mg 5mg Ask for price
Description: SIS3 free base

MS023 free base
407274 10.0mg
EUR 150

LYS01 free base
407398 10.0mg
EUR 150

ML298 free base
407464 5.0mg
EUR 240

M2698 free base
407496 200.0mg
EUR 2950

AZ505 free base
407948 5.0mg
EUR 150

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © 2024 Rhodococcus Genome Project, Genome BC Team, Canada - WordPress Theme : by Sparkle Themes